The control of endocannabinoid actions on cortical neurons by a putative carrier-mediated uptake is still poorly understood at the level of synaptic transmission. We investigated the effect of an endocannabinoid, 2-arachidonoyl glycerol (2-AG), on inhibitory postsynaptic currents (IPSCs) in hippocampal slices under physiological conditions, and when uptake was altered by a selective blocker or lower temperature. Bath application of 2-AG (20 mM) caused a 40% reduction in the amplitude of IPSCs evoked in the perisomatic region of CA1 pyramidal neurons at room temperature; this effect could be blocked by a speci®c CB 1 receptor antagonist, AM251. By contrast, a smaller (20%) but signi®cant suppression of inhibitory transmission was found by 2-AG at 33±35 8C. This reduced blocking effect at physiological temperature could be brought back to 40% by coapplying the endocannabinoid uptake blocker, AM404 (10 or 20 mM) with 2-AG. In parallel experiments, we measured [ 3 H]2-AG uptake at different temperatures in primary cultures prepared from cortical neurons. These data con®rmed a striking inhibition of [ 3 H]2-AG uptake at room temperature compared with values observed at 37 8C. Uptake could be signi®cantly modi®ed by anandamide, 2-AG and AM404, suggesting a common transporter for the two endocannabinoids. These ®ndings together demonstrate the presence of an effective endocannabinoid uptake in cortical neurons, which could considerably alter the spatial and temporal constraints of endocannabinoid signalling at physiological temperature, and which may critically change the interpretation of ®ndings at room temperature.
Introduction
The brain endocannabinoid system consists of signal molecules (endocannabinoids), enzymes for their synthesis and degradation, speci®c cell-surface receptors and a putative transport system (see for review Freund et al., 2003) . Most studies have investigated the functional roles of this signalling system in normal and pathological neuronal activity using plant-derived or synthetic cannabinoid agonists such as delta-9-tetrahydrocannabinol or WIN55,212-2. The main advantage of these compounds is that they are resistant to deactivation, whereas endocannabinoid substances are rapidly eliminated by uptake and intracellular hydrolysis (Freund et al., 2003) . Two endocannabinoids have been extensively characterized ± anandamide and 2-arachidonoyl glycerol (2-AG). Both activate CB 1 cannabinoid receptors (Devane et al., 1992; Sugiura et al., 1995) and are taken up by neurons and astrocytes (Beltramo et al., 1997; Beltramo & Piomelli, 2000; Hillard & Jarrahian, 2000; Bisogno et al., 2001 ) en route to intracellular degradation by distinct serine hydrolase enzymes: anandamide is broken down by fatty acid amide hydrolase (FAAH), and 2-AG by a monoglyceride lipase (MGL) (Cravatt et al., 1996; Dinh et al., 2002) .
In the hippocampus, the endocannabinoid system is thought to play a role in important signalling events such as depolarization-induced suppression of inhibition (DSI; Ohno-Shosaku et al., 2001; Wilson & Nicoll, 2001) or regulation of neuronal excitability via long-term depression of inhibition (I-LTD; Chevaleyre & Castillo, 2003) . In these events, the endocannabinoids may act as retrograde messengers, suppressing GABA release and inhibitory postsynaptic currents by engaging CB 1 receptors present on axon terminals of cholecystokinincontaining GABAergic interneurons (Katona et al., 1999; Ha Âjos et al., 2000) .
The clearance of endocannabinoids via uptake and/or degradation is a critical factor in determining the spatial and temporal constraints of their actions. The time-course of DSI is considerably shorter at physiological temperature than at room temperature (Kreitzer & Regehr, 2001) , which may re¯ect the temperature dependence of uptake (Vizi, 1998) . By contrast, the induction of I-LTD requires the presence of 2-AG for at least 5±10 min, which may be possible if uptake is slowed by subphysiological temperature. Indeed, the I-LTD experiments of Chevaleyre & Castillo (2003) were carried out at 25 8C. For a better prediction of the signi®cance of endocannabinoidmediated phenomena under physiological conditions, the temperature dependence of 2-AG uptake and action on GABAergic currents should be investigated.
In the present report, we have used freshly dissected slices of rat hippocampus to investigate the effects of ambient temperature and endocannabinoid transport blockade on the ability of 2-AG to inhibit GABAergic transmission. We have selected 2-AG for these experiments because of its higher abundance in the hippocampus relative to anandamide and its possible roles in I-LTD (Chevaleyre & Castillo, 2003 Student's paired t-test and Mann±Whitney U-test were used to compare changes in the mean amplitude after drug application; a value of P < 0.05 was considered signi®cant. Data are presented as mean AE SEM. The drugs were perfused until the maximal effect was seen. The time needed for the maximal inhibition (at least 3±5 min) correlated with the depth of the recorded cells. In some cases, we applied 2-AG for 7± 15 min at 33±35 8C. The longer application did not cause further change in the amplitude compared with the effect seen after 5 min, suggesting that this time period was enough at a¯ow rate of 3.5± 4.0 mL/min to equilibrate the drug effect. To quantify the drug effects, control IPSC amplitudes in a 2±3 min time window were compared with those measured after 5 min drug application for the same period of time.
Reagents for electrophysiological recordings 2-AG (26.4 mM stock solution in acetonitrile) was purchased from Sigma or Cayman Chemical. AM251 and AM404 [100 mM stock solution in dimethylsulphoxide (DMSO) or 50 mM in ethanol, respectively] were obtained from Tocris (UK). AM374 and URB597 were dissolved in DMSO. Solvents on their own had no effect on postsynaptic currents (n 8). The perfusion of the drugs did not change the holding current during the recordings. Kynurenic acid was purchased from Sigma.
Uptake experiments
We prepared primary cultures of rat cortical neurons from 18-day-old Wistar rat embryos in 24-well plates, as described by Stella & Piomelli (2001) . We incubated the neurons in Krebs'±Tris buffer containing [ 3 H]2-AG (American Radiolabelled Chemicals, 200 Ci/mol; 0.45 nM, brought to 30 nM with nonradioactive 2-AG) for 2±20 min at 37, 22 and 4 8C, rinsed them three times with 0.5 mL Krebs'±Tris buffer containing fatty acid-free bovine serum albumin (BSA, 0.1%), and extracted internalized tracer with 0.5 mL sodium hydroxide (0.1 M). We measured radioactivity by liquid scintillation counting.
Results
Temperature-dependence of the suppression of monosynaptically evoked inhibitory postsynaptic currents by 2-AG We investigated the action of 2-AG on inhibitory neurotransmission in the hippocampal slice preparation. Inhibitory postsynaptic currents (IPSCs) recorded in CA1 pyramidal cells were evoked in the presence of an ionotropic glutamate receptor blocker, kynurenic acid (2±3 mM), by stimulating GABAergic ®bres terminating in the perisomatic region (Ha Âjos et al., 2000) . First we tested the effect of 2-AG on GABAergic inhibition at room temperature (22±25 8C), at which transporter activity for various transmitters is known to be considerably reduced or even blocked (Vizi, 1998) . Bath application of 2-AG (20 mM) signi®cantly reduced the amplitude of evoked IPSCs (eIPSCs) (58.9 AE 6.5%, n 7, P < 0.001), an effect that was reversed upon washout ( Fig. 1A and D) . Pretreatment with or concomitant application of the CB 1 receptor antagonist AM251 (2 mM) abolished the effect of 2-AG (98.5 AE 4.8%, n 3, P > 0.05; Fig. 1B and D) . Next, we examined the action of 2-AG on inhibitory synaptic transmission at 33±35 8C. Application of 20 mM 2-AG produced a substantially smaller, albeit signi®cant decrease of eIPSCs (78.9 AE 2.7%, n 9, P < 0.01; Fig. 1C and D) , which contrasted with the change observed at room temperature (Mann±Whitney U-test, P < 0.02).
The endocannabinoid uptake inhibitor, AM404, enhances the suppression of evoked IPSCs by 2-AG at physiological temperature
In further investigations, we examined the effect of the endocannabinoid transport inhibitor AM404 on the action of 2-AG at 33±35 8C. In these experiments, 2-AG was applied at 10 mM, which reduced eIPSC amplitude (78.1 AE 2.5%, n 12, P < 0.001; Fig. 2A and D) to a similar extent as at 20 mM (Mann±Whitney U-test, P > 0.05; Fig. 1D ). When 2-AG (10 mM) application was either followed by a washing in of 2-AG together with AM404 (10 or 20 mM; Fig. 2C ), or this mixture was directly applied (Fig. 2B) , the inhibition of eIPSC amplitude was markedly enhanced at physiological temperature (63.1 AE 3.9%, n 7, P < 0.001; 61.1 AE 4.7%, n 12, P < 0.01, respectively), an effect that could be fully reversed by AM251 (102.3 AE 4.6% of control, n 3, P > 0.05). Irrespective of the application method, 10 or 20 mM AM404 enhanced the effect of 2-AG to a similar degree (10 mM, 62.1 AE 5.4%; 20 mM, 62.8 AE 4.5%; Mann±Whitney U-test, P > 0.05; Fig. 2D ). Application of AM404 alone had no signi®cant impact on the amplitude of eIPSC (10 mM, 94.8 AE 5%; 20 mM, 102.5 AE 8.1%; P > 0.05; Fig. 2D ). To exclude the possibility that the enhancement of the action of 2-AG with AM404 is not due to its impact on FAAH activity, we coapplied 2-AG (10 mM) with a speci®c FAAH inhibitor, URB597 (100±200 nM). The perfusion of this mixture caused a similar reduction in IPSC amplitude (76.2 AE 1.6%, n 4, P < 0.05) as with 2-AG application alone, indicating that the enhancement produced by AM404 is most likely mediated by inhibition of the transporter rather than reducing FAAH activity. The IPSC amplitude was not affected by URB597 application alone (96.7 AE 2.2% of control, n 4, P > 0.05). In summary, these results demonstrate that there is no signi®cant difference in the 2-AG-induced reduction of eIPSC amplitude at physiological temperature and at room temperature, if at the former AM404 is applied together with 2-AG (Mann±Whitney U-test, P > 0.05). These data imply that 2-AG uptake is considerably reduced at room temperature in slice preparations.
2-AG uptake by cortical neurons in culture is highly temperaturedependent

Human astrocytoma cells accumulate exogenous [
3 H]2-AG through a saturable and temperature-dependent process (Beltramo & Piomelli, 2000) . The fact that this process is inhibited by either nonradioactive 2-AG or anandamide, as well as by the anandamide transport inhibitor AM404, suggests that astrocytoma cells may accumulate both endocannabinoids through a common carrier-mediated mechanism. To determine whether neurons internalize 2-AG, we incubated primary cultures of rat cortical neurons in Krebs' buffer containing [ 3 H]2-AG (30 nM). After incubation, which lasted 2±20 min, we rinsed the cultures with buffer containing fatty-acid-free BSA, to eliminate residual tracer, and measured radioactivity in the cell extracts. The results of these experiments indicate that cortical neurons rapidly accumulate [ 3 H]2-AG in a strikingly temperature-dependent manner (Fig. 3A) . Next, we incubated the neurons for 4 min in Krebs' buffer containing [ 3 H]2-AG (30 nM) plus a large excess of nonradioactive 2-AG or anandamide (10 or 50 mM). Both compounds prevented [ 3 H]2-AG internalization in a concentration-dependent manner (Fig. 3B) . Moreover, AM404 (10 mM) signi®cantly reduced [ 3 H]2-AG accumulation (Fig. 3B ). This effect cannot be attributed to inhibition of FAAH activity by AM404, because two potent FAAH inhibitors, AM374 and URB597, had no effect on [ 3 H]2-AG accumulation (AM374, 112%; URB597, 99% of control; n 8). These ®ndings indicate that rat brain neurons may internalize 2-AG via a carrier-mediated process similar to that previously described for astrocytoma cells (Beltramo & Piomelli, 2000) , and that this uptake is highly temperature-dependent.
Discussion
The 2-AG-mediated suppression of inhibitory synaptic transmission in the hippocampus is probably due to the activation of CB 1 cannabinoid receptors. Our previous observations showed that CB 1 receptors are selectively present on axon terminals and preterminal axon segments of a subset of GABAergic interneurons expressing cholecystokinin, and their activation reduces GABA release as well as inhibitory postsynaptic currents (Katona et al., 1999; Ha Âjos et al., 2000) . In addition, our electrophysiological recordings provided direct evidence that cannabinoid actions on GABAergic IPSCs are entirely mediated by CB 1 receptors, because cannabinoid ligands have no effect on GABAergic currents in CB 1 knockout mice (Ha Âjos et al., 2000) . The temperature dependence of [ 3 H]2-AG transport has been demonstrated in astrocytoma and other cells (Beltramo & Piomelli, 2000; Bisogno et al., 2001 ). Here we provide the ®rst measurements of have not yet been identi®ed, uptake studies in vitro have provided evidence for the presence of endocannabinoid transport in several brain regions including the hippocampus (Giuffrida et al., 2001) . Together, our physiological and biochemical data indicate that the effect of 2-AG is profoundly reduced by its uptake at physiological, but not at ambient temperature. A similar ®nding has been reported for anandamide in the midbrain (Vaughan et al., 2000) .
As suggested by biochemical studies, endocannabinoid uptake can be saturated (Bisogno et al., 2001) . Therefore, the question arises as to why we did not see a larger reduction in IPSC amplitude after longer (7±15 min) applications of 2-AG at physiological temperature, as could be predicted from the saturation of uptake. One possibility might be that after uptake 2-AG is metabolized intracellularly, which may allow a constant siphoning of 2-AG from the extracellular space (Beltramo & Piomelli, 2000) . Kinetic analyses of anandamide internalization have led to the suggestion that uptake in neuroblastoma and astrocytoma cell lines requires FAAH activity and that no anandamide transporter exists in these cells (Glaser et al., 2003) . These ®ndings cannot be generalized to the brain, however, because pharmacological inhibition of FAAH activity in neurons or astrocytes has no effect on anandamide transport (Beltramo et al., 1997; Kathuria et al., 2003) . Most studies on the short-(DSI) or long-term (I-LTD) effects of endocannabinoids at inhibitory synapses have been performed at room temperature (Wilson & Nicoll, 2001; Chevaleyre & Castillo, 2003) , at which, according to the present results, endocannabinoid uptake is greatly reduced. This might explain why AM404 increases the magnitude and time course of DSI at 33 8C (Trettel & Levine, 2003) but not at 22 8C (Wilson & Nicoll, 2001) . Considering these results, the time window for DSI or for I-LTD at inhibitory synapses in the central nervous system should be narrower than suggested by the experiments performed at room temperature (Wilson & Nicoll, 2001; Chevaleyre & Castillo, 2003) . Data by Kreitzer & Regehr (2001) and our present ®ndings imply that this time period, when the CB 1 -expressing subset of inhibitory afferents is temporarily silenced by endocannabinoids, is likely to be in the range of 1±2 s in vivo. This time might still be long enough to allow short-or long-term modi®cations to take place at certain excitatory inputs (Carlson et al., 2002) , but may also ensure speci®city in space and time. 2-AG actions at GABAergic synapses 2995
